Medik8 Crystal Retinal Ceramide Eye 3
Introducing the world’s first clinical-strength retinal for the under-eye area: now expertly optimised for the delicate, sensitive skin around the eyes. Crystal Retinal Ceramide Eye 3 is the ideal entry-level strength for those new to vitamin A eye care or currently using Crystal Retinal 1 to 3 on the face.
Inspired by Medik8’s award-winning Crystal Retinal facial serum, this advanced overnight eye cream has been completely reinvented for the eye contour. Featuring twin-encapsulated 0.03% retinaldehyde, it delivers a controlled, ultra-gentle release of vitamin A while maintaining exceptional potency. The result is a visibly smoother, brighter and more youthful eye area, without irritation.
Powered by Medik8’s patent-pending retinal stabilisation system, skin-strengthening ceramides and moisture-plumping hyaluronic acid filling spheres, this eye-specialist formula helps to visibly reduce wrinkles, crow’s feet, dark circles and dehydration lines. With progressive retinal laddering (0.03% to 0.1%), results continually improve, ensuring your skin never plateaus.
Benefits
- Visibly softens crow’s feet, wrinkles and fine dehydration lines
- Brightens dark circles and improves signs of tiredness
- Plumps and firms the eye contours for a lifted look
- Delivers fast overnight smoothing results
- Ultra-gentle on sensitive skin and the delicate eye area
- Deep hydration and long-lasting moisture barrier support
- The perfect introductory strength retinal eye cream
Key Ingredients
-
0.03% Twin-Encapsulated Retinaldehyde: Proven to work up to 11× faster than retinol with a slowed, gentle release
-
Retinal Stabilisation System: Protects retinal potency for consistent, long-term performance
-
Ceramides: Reinforce the skin barrier and boost moisture retention
-
Hyaluronic Acid Filling Spheres: Immediately plump fine lines for a smoother appearance
-
Chamomile Extract: Calms and soothes to minimise irritation
*Proven via independent consumer study on Crystal Retinal Ceramide Eye 3 conducted over 6 weeks on 50 participants.